Gastrointestinal Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Gastrointestinal
| Protocol | Alliance A092001 |
|---|---|
| Cancer Type: | RARE |
PHASE 2 RANDOMIZED TRIAL OF NEOADJUVANT OR PALLIATIVE CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY FOR PERITONEAL MESOTHELIOMA
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG GI008 |
|---|---|
| Cancer Type: | Colon Adjuvant |
| Fast Facts |
COLON ADJUVANT CHEMOTHERAPY BASED ON EVALUATION OF RESIDUAL DISEASE (CIRCULATE-US)
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | SWOG S2001 |
|---|---|
| Cancer Type: | Metastatic Pancreatic |
| Fast Facts |
Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations.
| Protocol | Alliance A021806 |
|---|---|
| Cancer Type: | RESECTABLE PANCREATIC CANCER |
| Fast Facts |
A PHASE III TRIAL OF PERIOPERATIVE VERSUS ADJUVANT CHEMOTHERAPY FOR RESECTABLE PANCREATIC CANCER
| Protocol | Alliance A022106 |
|---|---|
| Cancer Type: | Pancreatic |
| Fast Facts |
A022106: “Phase II/III second-line NABPLAGEM vs. nab-paclitaxel/gemcitabine in BRCA1/2 or PALB2 mutant metastatic pancreatic ductal adenocarcinoma
| Protocol | SWOG S2408 |
|---|---|
| Cancer Type: | Pancreatic |
| Fast Facts |
S2408, A Randomized Phase III Blinded Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula”
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | SWOG S1922 |
|---|---|
| Cancer Type: | Small bowel Adenocarcinoma |
| Fast Facts |
Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | EAY191 - A6 |
|---|---|
| Cancer Type: | Rare Cancer |
A COMBOMATCH TREATMENT TRIAL: FOLFOX IN COMBINATION WITH BINIMETINIB AS 2ND LINE THERAPY FOR PATIENTS WITH ADVANCED BILIARY TRACT CANCERS WITH MAPK PATHWAY ALTERATIONS
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | EA2222 |
|---|---|
| Cancer Type: | Colorectal |
| Fast Facts |
A Randomized Phase III Study of Systemic Therapy With or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial.
| Protocol | CCTG CO32 |
|---|---|
| Cancer Type: | Early Rectal Cancer |
| Fast Facts |
The NEO-RT Trial: A Phase 3 Randomized Trial of Neoadjuvant Chemotherapy, Excision and Observation Versus ChemoRadioTherapy for Early Rectal Cancer
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | PDM 9846 |
|---|---|
| Cancer Type: | Tissue Procurement |
| Fast Facts |
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | WF 1806 |
|---|---|
| Cancer Type: | Cancer Control |
| Fast Facts |
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
Please check out the rare protocol list to locate other studies within this disease site.
Please check out the rare protocol list to locate other studies within this disease site.
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
